Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.

Lebensburger JD, Pestina TI, Ware RE, Boyd KL, Persons DA
Haematologica. 2010 95 (9): 1599-603

PMID: 20378564 · PMCID: PMC2930964 · DOI:10.3324/haematol.2010.023325

MeSH Terms (10)

Anemia, Sickle Cell Animals Blood Cell Count Disease Models, Animal Fetal Hemoglobin Genetic Therapy Hydroxyurea Mice Mice, Inbred C57BL Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links